Neurogenic Lower Urinary Tract Dysfunction

The reconstructive management of neurogenic lower urinary tract dysfunction (NLUTD) — framed around lesion-level pathophysiology, the AUA/SUFU 2021 risk-stratification framework, and the distinct natural history of each disease population.

• Neurogenic Lower Urinary Tract DysfunctionAnchor article — pathophysiology, evaluation, reconstructive ladder, surveillance
• Autonomic DysreflexiaPotentially life-threatening BP rise after SCI at or above T6
• Spinal Cord InjurySpinal shock, level-based phenotype, BoNT and augmentation, AD prophylaxis, fertility
• Multiple SclerosisChanging bladder symptoms, medication choices guided by cognition, MRI-conditional implant selection
• Spina BifidaPediatric CIC, augmentation + Mitrofanoff + MACE, tethered cord, transition to adult care
• Parkinson's DiseaseSuprapontine OAB, β3 agonist or antimuscarinic options, PD-vs-MSA differentiation for BPH surgery
• Stroke & DementiaFunctional incontinence, caregiver-directed toileting, trajectory-based decisions
• Cauda EquinaAcute emergency recognition, chronic sacral phenotype, CIC, selective outlet surgery